TCF12 and neoplasm: In this study, we identified a subset (8.3%) of CRC patients who, irrespective of tumor metastasis, have a poorer prognosis due to their tumor tissues exhibiting high TCF12 mRNA, high MALAT1, low β-catenin mRNA, and high cyclin D1 mRNA levels, referred to as the TMBC pattern.